Cargando…

Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management

Unlike conventional Coronavirus 2019 (COVID-19) vaccines, intranasal vaccines display a superior advantage because the nasal mucosa is often the initial site of infection. Preclinical and clinical studies concerning intranasal immunization elicit high neutralizing antibody generation and mucosal IgA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chavda, Vivek P., Vora, Lalitkumar K., Pandya, Anjali K., Patravale, Vandana B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Keynote (Green)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319039/ https://www.ncbi.nlm.nih.gov/pubmed/34332100 http://dx.doi.org/10.1016/j.drudis.2021.07.021

Ejemplares similares

The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects
por: Qiu, Tingting, et al.
Publicado: (2021)

AI-based language models powering drug discovery and development
por: Liu, Zhichao, et al.
Publicado: (2021)

Advances in the computational landscape for repurposed drugs against COVID-19
por: Aronskyy, Illya, et al.
Publicado: (2021)

Structure-based drug repurposing: Traditional and advanced AI/ML-aided methods
por: Choudhury, Chinmayee, et al.
Publicado: (2022)

Repurposing of cyclophilin A inhibitors as broad-spectrum antiviral agents
por: Han, Jinhe, et al.
Publicado: (2022)

Recent insights into viral infections as a trigger and accelerator in alzheimer's disease
por: De Vlieger, Lize, et al.
Publicado: (2022)

Co-infection associated with SARS-CoV-2 and their management
por: Chavda, Vivek P, et al.
Publicado: (2023)

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
por: Kronenberger, Thales, et al.
Publicado: (2023)

Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
por: Chavda, Vivek P., et al.
Publicado: (2023)

Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
por: Chavda, Vivek P., et al.
Publicado: (2022)

Potential Anti-SARS-CoV-2 Prodrugs Activated by Phosphorylation and Their Role in the Aged Population
por: Chavda, Vivek P., et al.
Publicado: (2023)

Inhalable Vaccines: Can They Help Control Pandemics?
por: Chavda, Vivek P., et al.
Publicado: (2022)

Conventional and Novel Diagnostic Tools for the Diagnosis of Emerging SARS-CoV-2 Variants
por: Chavda, Vivek P., et al.
Publicado: (2023)

Building Power Between Polarities: On the Space-in-Between
por: Ventres, William B.
Publicado: (2016)

Having seen it all: my vision of atrial fibrillation treatment in 2022
por: Cox, James L
Publicado: (2018)

Advances in the development of entry inhibitors for sialic-acid-targeting viruses
por: Heida, Rick, et al.
Publicado: (2021)

Keynotes
Publicado: (2023)

COVAX-19Ⓡ Vaccine: Completely blocks virus transmission to non-immune individuals
por: Chavda, Vivek P., et al.
Publicado: (2021)

A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2
por: Mhatre, Susmit, et al.
Publicado: (2021)

ART achievements and challenges in Africa
por: Hakim, J
Publicado: (2010)

Entry-inhibitory role of catechins against SARS-CoV-2 and its UK variant
por: Mhatre, Susmit, et al.
Publicado: (2021)

Finnish challenges and solutions on community mental health services
por: Hänninen, Esko
Publicado: (2010)

Ten Global Challenges in Medical Education: Wicked Issues and Options for Action
por: Mennin, Stewart
Publicado: (2021)

Intranasal SARS-CoV-2 Vaccines: Indispensable and Inevitable
por: Adashi, Eli Y., et al.
Publicado: (2022)

25 years after discovering HIV as the cause of aids: prospects for a vaccine
por: Gallo, Robert C
Publicado: (2010)

Towards ethical guidelines for dealing with unsolicited patient emails and giving teleadvice in the absence of a pre-existing patient-physician relationship — systematic review and expert survey
por: Eysenbach, Gunther
Publicado: (2000)

One-pot multicomponent nitro-Mannich reaction using a heterogeneous catalyst under solvent-free conditions
por: Bosica, Giovanna, et al.
Publicado: (2018)

Computer-aided simulation and exergy analysis of TiO(2) nanoparticles production via green chemistry
por: Meramo-Hurtado, Samir, et al.
Publicado: (2019)

Den Umweltschutz immer im Fokus: Nachhaltiges Hygienemanagement in Zeiten der Pandemie
por: Dikken, Birke
Publicado: (2021)

Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants
por: Teli, Divya, et al.
Publicado: (2023)

Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges
por: Kar, Sanchita, et al.
Publicado: (2022)

A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals
por: Chavda, Vivek P, et al.
Publicado: (2021)

mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics
por: Chavda, Vivek P., et al.
Publicado: (2022)

Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer
por: Khadela, Avinash, et al.
Publicado: (2022)

Can imaging help improve the survival of cancer patients?
por: Miles, K.
Publicado: (2011)

PET-CT in oncology: making the most of CT
por: Miles, K.A.
Publicado: (2008)

The clinical role of CT/PET in oncology: an update: Tuesday 4 October 2005, 08:15–08:45
por: Francis, Isaac R, et al.
Publicado: (2005)

Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques
por: Yu, Jingyou, et al.
Publicado: (2022)

Molecular imaging: what can be used today: Monday 3 October 2005, 11:15–12:00
por: Jager, P L, et al.
Publicado: (2005)

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
por: Hassan, Ahmed O., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1uknvd529r5l61f2v34j4eabbd